Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-96.59%
NET PROFIT MARGIN AVG 15Y
-121.86%
NET PROFIT MARGIN AVG 20Y
-199.25%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$5.32M
Net Profit Margin
-4011.86%
TTM Avg
-2005.93%
3Y Avg
-2671.67%
5Y Avg
-1781.12%
Market Cap
$5.35M
Net Profit Margin
-3985.58%
TTM Avg
-1467.13%
3Y Avg
-2181.72%
5Y Avg
-1717.85%
Market Cap
$5.24M
Net Profit Margin
-294.91%
TTM Avg
-320.57%
3Y Avg
-453.36%
5Y Avg
-361.46%
Market Cap
$5.22M
Net Profit Margin
0.00%
TTM Avg
-61.23%
3Y Avg
-156.55%
5Y Avg
-194.88%
Market Cap
$5.21M
Net Profit Margin
-106.78%
TTM Avg
-43.08%
3Y Avg
-12.30%
5Y Avg
-12.30%
Market Cap
$5.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.12M
Net Profit Margin
-612568.11%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Soligenix, Inc. (SNGX) | $5.31M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -4011.86% | -2005.93% | -2671.67% | -1781.12% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -294.91% | -320.57% | -453.36% | -361.46% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | 0.00% | -61.23% | -156.55% | -194.88% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | -106.78% | -43.08% | -12.30% | -12.30% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | -612568.11% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -1636.63% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | -406.76% |
| 2022-12-31 | -1876.78% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -8698.04% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -7083.68% |
| 2020-12-31 | -1939.09% |
| 2020-09-30 | -352.97% |
| 2020-06-30 | -949.45% |
| 2020-03-31 | -897.00% |
| 2019-12-31 | -505.38% |
| 2019-09-30 | -216.81% |
| 2019-06-30 | -137.48% |
| 2019-03-31 | -143.23% |
| 2018-12-31 | -305.91% |
| 2018-09-30 | -134.83% |
| 2018-06-30 | -113.74% |
| 2018-03-31 | -305.81% |
| 2017-12-31 | -165.94% |
| 2017-09-30 | -52.86% |
| 2017-06-30 | -233.27% |
| 2017-03-31 | -130.25% |
| 2016-12-31 | -19.42% |
| 2016-09-30 | -56.54% |
| 2016-06-30 | -2.94% |
| 2016-03-31 | -43.67% |
| 2015-12-31 | -69.26% |
| 2015-09-30 | 71.49% |
| 2015-06-30 | -361.64% |
| 2015-03-31 | -559.73% |
| 2014-12-31 | 99.84% |
| 2014-09-30 | -156.03% |
| 2014-06-30 | -66.93% |
| 2014-03-31 | -365.91% |
| 2013-12-31 | 72.04% |
| 2013-09-30 | -2099.26% |
| 2013-06-30 | -538.53% |
| 2013-03-31 | -120.73% |
| 2012-12-31 | -122.71% |
| 2012-09-30 | -81.47% |
| 2012-06-30 | -128.47% |
| 2012-03-31 | -222.23% |
| 2011-12-31 | -142.70% |
| 2011-09-30 | 38.04% |
| 2011-06-30 | -475.83% |
| 2011-03-31 | -212.87% |
| 2010-12-31 | -632.27% |
| 2010-09-30 | -201.48% |
| 2010-06-30 | -354.73% |
| 2010-03-31 | -636.18% |
| 2009-12-31 | -37.41% |
| 2009-09-30 | -216.53% |
| 2009-06-30 | -537.11% |
| 2009-03-31 | -404.48% |
| 2008-12-31 | -59.04% |
| 2008-09-30 | -78.53% |
| 2008-06-30 | -260.47% |
| 2008-03-31 | -200.13% |
| 2007-12-31 | -381.19% |
| 2007-09-30 | -290.37% |
| 2007-06-30 | -556.63% |
| 2007-03-31 | -920.18% |
| 2006-12-31 | -260.83% |
| 2006-09-30 | -1157.40% |
| 2006-06-30 | -2411.75% |
| 2006-03-31 | -122.98% |
| 2005-12-31 | -282.17% |
| 2005-09-30 | -157.79% |
| 2005-08-12 | -38.06% |
| 2005-03-31 | -906.57% |
| 2004-12-31 | -196.45% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | -1763.58% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
